Literature DB >> 24745681

Bone involvement and osteoporosis in mastocytosis.

Maurizio Rossini1, Roberta Zanotti2, Ombretta Viapiana2, Gaia Tripi2, Giovanni Orsolini2, Luca Idolazzi2, Patrizia Bonadonna2, Donatella Schena2, Luis Escribano2, Silvano Adami2, Davide Gatti2.   

Abstract

Bone involvement is frequent in patients with systemic mastocytosis. Osteoporosis is the most prevalent bone manifestation, but diffuse osteosclerosis or focal osteolytic or osteosclerotic lesions are not infrequent. The risk of osteoporotic fractures is high, especially at the spine and in men. Routine measurements of bone mineral density and vertebral morphometry are warranted. The bone turnover markers indicate the involvement of complex bone metabolism in mastocytosis-related manifestations. Bisphosphonates represent the first-line treatment for osteoporosis-related mastocytosis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone mineral density; Bone turnover markers; Fracture; Mastocytosis; Osteoporosis; Osteosclerosis

Mesh：

Substances：

Year:  2014        PMID： 24745681     DOI： 10.1016/j.iac.2014.01.011

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN： 0889-8561            Impact factor:   3.479


  20 in total

1.  Impaired function of bone marrow stromal cells in systemic mastocytosis.

Authors:  Krisztian Nemeth; Todd M Wilson; Jiaqiang J Ren; Marianna Sabatino; David M Stroncek; Miklos Krepuska; Yun Bai; Pamela G Robey; Dean D Metcalfe; Eva Mezey
Journal:  Stem Cell Res       Date:  2015-05-08       Impact factor: 2.020

2.  Bone mineral density and microarchitecture in patients with essential thrombocythemia and polycythemia vera.

Authors:  S Farmer; V V Shanbhogue; S Hansen; C I Stahlberg; H Vestergaard; A P Hermann; H Frederiksen
Journal:  Osteoporos Int       Date:  2016-10-13       Impact factor: 4.507

Review 3.  Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association.

Authors:  Patrizia Bonadonna; Massimiliano Bonifacio; Carla Lombardo; Roberta Zanotti
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

Review 4.  Endocrine manifestations of systemic mastocytosis in bone.

Authors:  Loren Wissner Greene; Kamyar Asadipooya; Patricia Freitas Corradi; Cem Akin
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 5.  Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.

Authors:  M Rossini; R Zanotti; G Orsolini; G Tripi; O Viapiana; L Idolazzi; A Zamò; P Bonadonna; V Kunnathully; S Adami; D Gatti
Journal:  Osteoporos Int       Date:  2016-02-18       Impact factor: 4.507

Review 6.  Focal bone involvement in inflammatory arthritis: the role of IL17.

Authors:  Maurizio Rossini; Ombretta Viapiana; Silvano Adami; Luca Idolazzi; Elena Fracassi; Davide Gatti
Journal:  Rheumatol Int       Date:  2015-10-31       Impact factor: 2.631

Review 7.  Rare causes of osteoporosis.

Authors:  Gemma Marcucci; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2015-10-26

Review 8.  Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.

Authors:  David González-de-Olano; Almudena Matito; Alberto Orfao; Luis Escribano
Journal:  F1000Res       Date:  2016-11-14

9.  Osteoporotic spinal burst fracture in a young adult as first presentation of systemic mastocytosis.

Authors:  Christina Ble; Parmenion P Tsitsopoulos; Dimitrios M Anestis; Sofia Hadjileontiadou; Triantafyllia Koletsa; Maria Papaioannou; Christos Tsonidis
Journal:  J Surg Case Rep       Date:  2016-05-02

10.  Increased Bone Mass in Female Mice Lacking Mast Cell Chymase.

Authors:  Thomas Lind; Ann-Marie Gustafson; Gabriela Calounova; Lijuan Hu; Annica Rasmusson; Kenneth B Jonsson; Sara Wernersson; Magnus Åbrink; Göran Andersson; Sune Larsson; Håkan Melhus; Gunnar Pejler
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.